Table 4.
Frequent co-occurring dyads (≥10 %) and observed and expected values
| Frequent co-occurring dyads (n) | Observed (%) | Expected (%) | Observed/expected | 95 % CI |
|---|---|---|---|---|
| HBP/spinal column disease (1591) | 23.6 | 20.7 | 1.14 | 1.06–1.23 |
| HBP/heart problem (1593) | 22.3 | 16.4 | 1.37 | 1.26–1.48 |
| HBP/cognitive impairment (1514) | 19.9 | 18.9 | 1.05 | 0.97–1.15 |
| HBP/eyesight problem (1547) | 17.1 | 15.2 | 1.13 | 1.03–1.23 |
| HBP/rheumatism (1592) | 17.0 | 15.1 | 1.13 | 1.03–1.23 |
| HBP/falls (1591) | 16.8 | 15.5 | 1.09 | 1.00–1.19 |
| Rheumatism/spinal column disease (1590) | 16.1 | 10.2 | 1.58 | 1.43–1.74 |
| Heart problem/spinal column disease (1591) | 12.9 | 11.1 | 1.17 | 1.06–1.30 |
| Spinal column disease/falls (1589) | 12.9 | 10.5 | 1.23 | 1.11–1.37 |
| HBP/urinary incontinence (1592) | 12.8 | 11.4 | 1.11 | 1.01–1.23 |
| Spinal column disease/eyesight problem (1545) | 12.4 | 10.3 | 1.20 | 1.08–1.34 |
| HBP/problem chewing food (1590) | 11.5 | 7.4 | 1.55 | 1.38–1.75 |
| Heart problem/cognitive impairment (1514) | 11.4 | 10.1 | 1.13 | 1.01–1.26 |
| Cognitive impairment/falls (1512) | 11.3 | 9.5 | 1.18 | 1.06–1.33 |
| Cognitive impairment/eyesight problem (1506) | 11.2 | 9.4 | 1.19 | 1.06–1.33 |
| Spinal column disease/cognitive impairment (1512) | 11.1 | 12.8 | 0.87 | 0.78–0.97 |
| HBP/depression (1512) | 11.0 | 10.0 | 1.11 | 0.99–1.24 |
| HBP/diabetes (1593) | 11.0 | 8.4 | 1.32 | 1.17–1.48 |
| Heart problem/eyesight problem (1547) | 10.7 | 8.1 | 1.32 | 1.17–1.48 |
| Rheumatism/falls (1590) | 10.4 | 7.6 | 1.37 | 1.21–1.54 |
| Eyesight problem/falls (1545) | 10.4 | 7.7 | 1.34 | 1.19–1.52 |
| Rheumatism/cognitive impairment (1513) | 10.1 | 9.3 | 1.09 | 0.97–1.22 |
% prevalence, CI confidence interval, n sample size available to analysis